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Abstract 
Reactive oxygen species are derived from oxygen and produced during microbial 
infections of mammals. NADPH oxidases, such as DUOX, catalyze the first step in ROS 
synthesis, forming superoxide and subsequently hydrogen peroxide.  C. elegans expresses a 
DUOX enzyme encoded by the gene bli-3.  It is believed that DUOX may be involved in host 
defenses in C. elegans against S. cerevisiae. Its activity can be measured by hydrogen peroxide 
production. In this study, a hydrogen peroxide-measuring assay was tested for the future 
identification of genes that are required for ROS production in C. elegans. In the Amplex Red 
assay, hydrogen peroxide production increased when worms were infected with S. cerevisiae, 
suggesting that DUOX expression or activity were induced by infection.  
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Background  
Reactive oxygen species (ROS) are highly unstable and reactive molecules that are 
derived from oxygen (Bedard & Krause, 2007). The phagocyte “respiratory burst” is the 
accompanying consumption of oxygen critical to the killing of certain pathogens. ROS are 
produced in large amounts by neutrophils and macrophages by the phagocyte NADPH 
oxidase in response to infection as a mammalian innate immune response (Bedard & 
Krause, 2007). For example, ROS are generated by Caenorhabditis elegans during yeast and 
bacterial infections (Chavez et al, 2009). NADPH oxidases create superoxides through 
electron transfer across biological membranes (Bedard & Krause, 2007). The enzyme 
NADPH oxidase catalyzes the first step in ROS synthesis by the reaction shown here, to 
produce superoxides:  
NADPH + 2O2  2O2
-
 + NADP
+
 + 2H
+
 
 Subsequent steps convert superoxide to hydrogen peroxide and other products, either 
through enzymatic activity or at low pH. These ROS forms lead to the killing of 
microorganisms (Bedard & Krause, 2007).  
Different isoforms of the NADPH oxidase are known, which include two different 
forms of DUOX (DUOX1 and DUOX2) and the five NOX catalytic subunits (NOX1, 
NOX2, NOX3, NOX4, and NOX5). Together, these are considered to be a NOX family of 
oxidases because of their sequence and domain conservation (Bedard & Krause, 2007).  For 
this study, the DUOX form is of greatest interest because it is part of the NOX family 
oxidases and it may be involved in host defenses in epithelial barrier tissues (Jain, et al, 
2009, Chavez, et al, 2009). During infection of C. elegans by the yeast S. cerevisiae, DUOX 
activity is induced and can be measured by a chemical assay for hydrogen peroxide 
production (Jain et al, 2009).  
 The objective of this study is to understand how DUOX activity is controlled in 
response to an infection in C. elegans by the yeast Saccharomyces cerevisiae. In the innate 
immune response of C. elegans to bacterial and fungal pathogens, what is known about the 
activation of the pathways that may regulate DUOX begins with two G proteins (Figure 1). 
These two G proteins include GPA-1 and RACK-1 (Ziegler et al 2009). Downstream of 
these G proteins is the C. elegans homolog of the p38 MAP kinase pathway of mammals. 
The G proteins activate PLCγ and PLCβ, which catalyze PIP2 cleavage, leading to two 
different pathway branches. The first pathway is downstream of DAG, which activates 
PKCδ, which then phosphorylates TIR-1. TIR-1 then activates ASK1 (NSY-1) which 
phosphorylates MKK6 (SEK-1). MKK6 phosphorylates P38 (PMK-1) which by inference 
phosphorylates an unknown transcription factor (Ziegler, et al., 2009). The other pathway is 
downstream of inositol trisphosphate (IP3), which activates the IP3 receptor, a Ca
2+
 channel 
(Murphy, 2012). We hypothesize that the Ca
2+
 release mediated by the IP3 receptor 
activates DUOX, which contains EF hand domains that bind Ca
2+ 
(Ziegler et al, 2009). 
Because PLCγ and PLCβ branch off into two different pathways, if these were mutated, 
these mutations would affect both pathways downstream of PIP2.  
  
 
 
Figure 1: Pathways downstream of PIP2 in C. elegans. Pathway components shown in red are 
steps hypothesized to be important in DUOX regulation. The parts shown in blue are steps 
that have already been well-established in other studies (adapted from Ziegler, et al, 2009).  
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 It is known that during a yeast infection, ROS is generated by C. elegans in an 
NADPH oxidase-dependent process (Jain et al, 2009). With this knowledge and our 
knowledge of the signaling pathways operating during microbial infections of C. elegans, 
we can focus on the downstream pathways that activate ROS production, because they are 
likely to activate DUOX activity in order to do so (Gravato-Nobre & Hodgkin, 2005).  
The host model organism used for this study was Caenorhabditis elegans. These 
organisms have proved useful for studying innate immune responses for several reasons. 
Firstly, the genome sequence of C. elegans has already been determined (The C. elegans 
Sequencing Consortium, 1998). Many C. elegans genes are similar to those of humans 
(Kamath, et al., 2003). Their innate immune defenses are similar to those of mammalian 
innate immunity, making C. elegans a valuable host model (Gravato-Nobre & Hodgkin, 
2005). Second, their morphology and unique characteristics allow for easy observation. 
These worms are microscopic but are also transparent which allows internal changes to be 
viewed in vivo (Gravato-Nobre & Hodgkin, 2005). Third, C. elegans reproduce by self-
fertilization, therefore creating natural clones which provide genetically identical organisms 
which can be used in large numbers throughout the course of the study (Schulenburg, 2004). 
C. elegans have two major barriers to systemic infection. These include the intestinal 
epithelium and the cuticle or body covering, which covers the hypodermis (Couillault, et al., 
2004). The hypodermis and intestine are prime candidates for immune tissues, based on 
proximity to potential pathogens (Breger, et al., 2007). Therefore, these worms have been 
used to study host-pathogen interactions (Gravato-Nobre & Hodgkin, 2005). Thus, for this 
experiment, the Amplex Red Assay will be used to test these interactions.  
The Amplex Red Assay is a test that can be used to determine if worms produce 
hydrogen peroxide during microbial infections (Zhou, et al, 1997). This test uses N-acetyl-3, 
7 dihydroxyphenoxazen, also known as Amplex Red, which is oxidized in the presence o f 
hydrogen peroxide (Zhou, et al, 1997). In our application, worms that have been in contact 
with yeast are placed in microtiter wells, and the reagents of the Amplex Red assay are 
added to the wells. As seen in Figure 2, horseradish peroxidase (HRP) oxidizes the Amplex 
Red to form a colored compound, resorufin, whose red color optical absorbance can be 
measured.  The absorbance in the microtiter well is proportional to the amount of hydrogen 
peroxide in the sample (Zhou, et al, 1997).  DPI is a NADPH dependent oxidase-specific 
inhibitor that can control the DUOX specificity.  It is important to do this in case there are 
other sources of ROS in C. elegans.  
 
Figure 2: The reaction that forms the basis of the Amplex Red Assay. In the presence of hydrogen 
peroxide, HRP oxidizes the Amplex Red producing a red color resorufin (adapted from Life 
Technologies, 2012). 
 
The Amplex Red assay will be used to measure NADPH oxidase-dependent 
production of hydrogen peroxide in C. elegans after yeast infection.  Jain et al (2009) and 
Chavez et al (2009) showed that hydrogen peroxide production is induced upon yeast or 
bacterial infection of wild type C. elegans, respectively.  The goal of this project is to use 
the Amplex Red assay to test if the genes hypothesized to induce C. elegans DUOX are 
indeed required for hydrogen peroxide production after infection.  If a reduction in 
hydrogen peroxide signal is observed in a loss of function mutant, it would suggest that the 
gene is required for hydrogen peroxide production by DUOX.  
This would lead to the hypothesis that DUOX is regulated in some way by this gene. 
For example, if there is a reduction in the induction of hydrogen peroxide in the presence of 
MAP kinase pathway mutations, this would suggest that H2O2 production requires activity 
of the p38 MAP kinase pathway.   
  
Materials and Methods 
Stocks 
The wild type strain of C. elegans, N2, was used for this experiment and was kept at 
20°C on NGM agar plates supplied with lawns of E. coli OP50. Every day, three to four worms 
were transferred to new agar plates with fresh E. coli in order to maintain stocks.  
Amplex Red Assay 
 The overall methods for this experiment are shown in Figure 3. More detailed steps 
follow.  
 
Figure 3: Basic flow chart of methods 
 
Egg Prep 
•The C. elegans and eggs were washed with sterile M9 and underwent a bleach treatment.  
•A large number of eggs were isolated and grown on new E. coli plates 
•Saccharomyces and E. coli liquid cultures were made and incubated overnight 
Spotting 
plates 
•The Saccharomyces culture was diluted 1:30 
•The E. coli culture was diluted 1:30 
•New plates were spotted with Saccharomyces or E. coli and incubated overnight 
Transferring 
Worms 
•When the worms grew to the L4 stage, they were washed with sterile M9 
•About 300 worms were transferred to each of the previously made yeast or E. coli plates 
and incubated overnight 
Amplex Red 
Assay 
•The Amplex Red Assay kit reagents were prepared 
•The infected worms were placed in the  reagent solution in microtiter wells 
•Different controls were used to compare the levels of hydrogen peroxide  produced 
Measuring 
Absorbance 
•Once the red color from the resorufin product was visible, the absorbance was measured 
•The absorbance was proportional to the hydrogen peroxide levels in the sample 
•Results were obtained and analyzed 
Egg Preparation Protocol 
For an “egg prep”, at least four plates were used with as many eggs on them as possible, 
which usually occurred when most of the E. coli had been eaten.   This stage took about four to 
five days from the date when the worms were plated.  
Using a 5¾” sterile glass Pasteur pipet, a pipetful of sterile M9 was pipetted onto the 
plate, which was held at an angle, so that the liquid could collect at the bottom of the plate, while 
not spilling. The M9 was sucked back up with the pipet and released over the plate several times 
until all of the worms and eggs on the plate were collected. The liquid was added to a 15 mL 
disposable plastic centrifuge tube.  Worms washed off different plates were combined into one or 
more 15 mL tubes as necessary. 
The liquid levels for each conical tube were made equal by adding as much sterile M9 as 
necessary before centrifugation. The tubes were centrifuged at 1139 x g for two minutes. After 
centrifugation, a pellet of worms was seen at the bottom of each sample tube. 
A Pasteur pipet attached to a vacuum system was used to remove as much of the M9 
supernatant as possible, without disturbing the pellet.  Sterile M9 was then added to the tubes to 
resuspend the worms so that they could be centrifuged and resuspended twice more, for a total of 
three centrifugations. 
A solution containing 75mL of distilled water, 1g NaOH, and 25mL of 5% commercial 
household bleach was mixed until all of the NaOH had dissolved. 
After the last centrifugation, as much M9 as possible was removed from the tubes 
without disturbing the worm pellets. A timer was set to 3:00 minutes to make sure the samples 
were not in the bleach solution for too long, as it could damage the eggs. The bleach solution was 
added to the sample tubes to the 10mL mark. The timer was started and the tube was capped and 
inverted a few times throughout the 3 minutes, to make sure the worms were in contact with the 
bleach. The samples were quickly put back into the centrifuge for another two-minute cycle at 
1139 x g. When the cycle was finished, the supernatants were quickly removed again, without 
disturbing the egg pellet but leaving as little bleach as possible. The samples were then washed 
quickly again three times with sterile M9 as described before.  
For experiments, eggs were grown on NGM/E.coli OP50 plates.  After the three washes 
with M9, the supernatants were removed to the 1mL mark. The egg pellet was resuspended by 
mixing, and using a glass 100 µL capillary pipet, 20µl of the egg suspension were quickly added 
to an E. coli plate. The number of eggs present were counted and multiplied by 50 to calculate 
the total number of eggs in the tube. The volume was adjusted as needed to obtain 5000 eggs/mL 
by adding more sterile M9, centrifuging at 1139 x g, and carefully vacuuming to the desired 
volume. No more than 50µl containing approximately 200 eggs were placed on each plate. After 
all the eggs were distributed to the plates, they were incubated at 20°C. 
Preparation of Yeast and E. coli Test Plates 
A single colony was picked from a YPD agar plate of S. cerevisiae (Y101), placed in a 
liquid culture containing 2mL of sterile YPD broth, and incubated overnight at 30°C in a rolling 
drum. The same was done for E. coli (OP50) grown on LB broth overnight in a 37°C incubator.  
The yeast liquid culture was diluted 1:30 with YPD by combining 10 µL of the Y101 
with 300 µL YPD in a sterile Eppendorf tube. This dilution was combined with YPD and 
Streptomycin sulfate (50 mg/mL stock, used to prevent contamination), in a 1:1:2 ratio. 20 µL of 
this mixture was spotted on NGM agar plates; the plates were then incubated overnight at 30°C. 
The overnight E. coli culture was diluted 1:30 with LB broth. From this dilution, 40µL were used 
to spot new plates. More E. coli was added than Saccharomyces because Saccharomyces grows 
faster than E. coli.   The E. coli plates were incubated at 37°C overnight. 
Transferring Worms to Yeast Plates 
The yeast and E. coli plates were removed from the incubator and kept at room 
temperature to cool. After the eggs had grown into L4 worms (about 48 hours after plating the 
eggs), the worms were washed off the E. coli growth plates with sterile M9 as described 
previously.   Worms were washed and centrifuged at 500 x g three times.  After the last 
centrifugation, the supernatant was removed and the volume was adjusted to provide 
approximately 300 worms in 50 µL. 
About 300 worms were added to each of 6-8 yeast plates in 50 µL or less. The same was 
done for the new E. coli plates, which were used as a control. The worms were left on the plates 
for about 24 hours in the 20°C incubator before performing the Amplex Red Assay. 
Amplex Red Assay  
The worms were washed off the E. coli and yeast plates with sterile M9 and centrifuged 
three times at 500 x g. Worms harvested from E. coli and yeast plates were kept in separate 
tubes. Between each centrifugation of the samples, the M9 was removed and more M9 was 
added to resuspend the worm and yeast pellet thoroughly, and the worms were allowed to settle 
on the benchtop. Once the worms had settled, the yeast was vacuumed off and M9 was added 
until it reached the top and centrifuged again. The worms were resuspended as many times 
needed in between centrifugations so that as much yeast as possible was removed from the 
supernatant so as to reduce sample turbidity during the Amplex Red Assay.  
The volume of the samples incubated with yeast and E. coli was adjusted with sterile M9 
to a concentration of 100 worms/50 µL.   
The Amplex Red kit was purchased from Invitrogen (catalog # A22188).  Amplex Red 
assays followed the instructions provided with the kit. All of the Amplex Red kit reagents were 
stored at -20° C when not in use.  Before starting the assay, one tube of Amplex Red reagent and 
a tube of Dimethylsulfoxide (DMSO) were allowed to warm to room temperature. The contents 
of the tube of Amplex Red reagent were dissolved in 60µL of DMSO. This was enough for 
approximately 100 assays. The Amplex Red reagent stock solution was used on the same day it 
was prepared. Because the Amplex Red reagent is light-sensitive, some experiments were 
performed in a dark room with minimal light.  
The 1X Amplex Red Reaction Buffer was made by adding 4mL of 5X Reaction Buffer to 
16mL of deionized water. This 20mL volume was sufficient for approximately 100 assays. 
The contents of the tube of HRP (10 U) provided in the kit were dissolved in 1.0 mL of 
1X Reaction Buffer. Any unused HRP stock solution was placed into single-use 100 µL aliquots 
and stored at -20°C. 
The stock solutions were used to prepare a reaction mix  by adding together 4.85 mL of 
1X Reaction Buffer, 50 µL of Amplex Red reagent stock solution (10 mM), and 100 µL of 10 
U/mL HRP stock solution. This 5mL volume was sufficient for approximately 100 assays.  
A 96 well microtiter plate (Costar 3596) was prepared by filling wells with 200 µL of 
0.05% Tween 20, to prevent sticking of worms to the bottoms of the wells. The Tween 20 
solution was removed by inverting the plate and flicking it over a trash barrel. 50 µL of the worm 
suspension containing 100 worms from either the yeast or E. coli incubation plates were added to 
each well. In three out of the six wells for each of the two strains (yeast and E. coli), 3µl of the 
NADH oxidase inhibitor DPI, dissolved to a stock concentration of 3.3mM in DMSO, was 
added. 3 µL of DMSO was added to wells which did not contain DPI. Lastly, 50µL of the 
Amplex Red reagent/HRP working solution was added to each of the wells.  
The plate was protected from light by wrapping it in aluminum foil and left at room 
temperature on a shaking platform. After about six hours on the platform, it was put in a 2°C 
fridge.  
Using a microtiter plate reader, the absorbance at 540nm was measured for each well.  
  
Results 
An Amplex Red assay was performed on worm samples grown on yeast or E. coli, as well as 
samples containing the Amplex Red reagents without worms, to use as a control. Each 
experimental condition was performed in triplicate.  Table 1 shows the results. 
Table 1: Resorufin A540 readings for yeast and E. coli worms 
Yeast 
1.093 
E. coli 
0.229 
No Worms 
0.188 
1.083 0.348 0.202 
1.021 0.219 0.200 
Mean 1.066 Mean 0.265 Mean 0.197 
 
 The mean absorbances from the wells without worms were subtracted from the mean 
absorbances of worm samples of yeast and E. coli. These corrected values are shown in Table 2. 
Table 2: Corrected Absorbances of yeast and E. coli samples 
 Corrected Mean Absorbances 
Yeast 1.066 – 0.197 = 0.869 
E. coli 0.265 – 0.197 = 0.069 
 
In order to check if the absorbances found in yeast and E. coli samples were significantly 
different, pairwise ANOVA tests were done.  The results were considered significant if the P-
value was less than 0.05. These results are shown in Table 3.  
  
Table 3: ANOVA results comparing yeast and E. coli worms 
SUMMARY 
Groups Count Sum Average Variance 
  Yeast 3 3.197248 1.065749 0.001549 
  E. coli 3 0.865482 0.288494 0.004214 
  
 ANOVA 
Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.906189 1 0.906189 314.4882 5.94007E-05 7.708647 
Within Groups 0.011526 4 0.002881 
   TOTAL 0.917714 5         
 
 Because the P-value was 0.000059, the differences measured are considered significant, 
and we can conclude that the absorbance difference was due to yeast infection.  
After determining the significance of differences between samples, the uncorrected mean 
absorbances from Table 2 were used to construct a graph for a better visual comparison.  This 
can be seen in Figure 4.  
 
Figure 4: Graph of mean absorbances from Amplex Red assay.  Error bars represent standard 
error.  
 As seen from Figure 4, the worm samples grown in yeast yielded significantly higher 
absorbances than those grown in E. coli, indicating that worms produced more hydrogen 
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peroxide when exposed to yeast.  The difference between absorbances for the yeast samples and 
no worm samples were also highly significant (ANOVA p = 0.000003) indicating that the 
increased hydrogen peroxide production depended on the presence of worms.  In contrast, the 
difference between absorbance for the E. coli and no yeast samples was not significant (ANOVA 
p = 0.17), indicating that contact with E. coli resulted in a minimal increase in hydrogen peroxide 
production. 
  
Discussion 
The purpose of this experiment was to understand how ROS production responds to a 
yeast infection in C. elegans through the measurement of hydrogen peroxide, using the Amplex 
Red Assay. When the Amplex Red reagent reacted with the worms and hydrogen peroxide was 
produced, a red color appeared and was measured for the absorbance. To check if the differences 
observed were significant, an ANOVA test was performed. The difference between the S. 
cerevisiae and E. coli samples was highly significant, as seen in Table 3 (ANOVA P = 
0.000059).  Once the results were graphed, as seen in Figure 4, it was clear that the samples of 
worms grown in yeast produced more hydrogen peroxide than the samples of worms in E. coli. 
An additional control was performed:  adding the inhibitor DPI, which is specific for NADPH 
oxidase.  However, this control did not work properly, possibly because of a problem with the 
DPI reagent (results not shown). Thus, although we would like to conclude from these results 
that a Saccharomyces infection induces the production of hydrogen peroxide by DUOX, we 
cannot eliminate the possibility that another cellular process created ROS under our conditions.  
In the study of Jain et al 2010, the Amplex Red assay did show diminished color in samples 
treated with DPI.  However, the resorufin absorbance was not measured in their assays. 
Thus the major contribution of this work has been to produce a quantitative version of the 
Amplex Red assay, which is now available for further experimentation to confirm the importance 
of DUOX under these experimental conditions.  Moreover, the use of this assay to test loss of 
function mutants for effects on ROS production will be validated if the result can be 
demonstrated to be abolished by addition of DPI. 
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